Cargando…
Intervention for early diabetic nephropathy by mesenchymal stem cells in a preclinical nonhuman primate model
BACKGROUND: Diabetic nephropathy (DN) is one of the most severe chronic diabetic complications and the main cause of end-stage renal disease. Chronic inflammation plays a key role in the development of DN. However, few treatment strategies are available; therefore, new and effective strategies to am...
Autores principales: | An, Xingxing, Liao, Guangneng, Chen, Younan, Luo, Ai, Liu, Jingping, Yuan, Yujia, Li, Lan, Yang, Lichuan, Wang, Hong, Liu, Fang, Yang, Guang, Yi, Shounan, Li, Yuanmin, Cheng, Jingqiu, Lu, Yanrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889652/ https://www.ncbi.nlm.nih.gov/pubmed/31791397 http://dx.doi.org/10.1186/s13287-019-1401-z |
Ejemplares similares
-
Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment
por: Li, Yuanmin, et al.
Publicado: (2018) -
Mesenchymal stem cells ameliorate hyperglycemia-induced endothelial injury through modulation of mitophagy
por: Zhu, Wuzheng, et al.
Publicado: (2018) -
A preclinical evaluation of alternative site for islet allotransplantation
por: Wang, Chengshi, et al.
Publicado: (2017) -
Mesenchymal Stem Cells Ameliorated Glucolipotoxicity in HUVECs through TSG-6
por: An, Xingxing, et al.
Publicado: (2016) -
Mesenchymal stem cells alleviate rat diabetic nephropathy by suppressing CD103(+) DCs‐mediated CD8(+) T cell responses
por: Zhang, Fuping, et al.
Publicado: (2020)